ClinicalTrials.Veeva

Menu

Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations

Y

Yunling Zhang

Status

Completed

Conditions

Ischemic Stroke

Treatments

Drug: Ixeris of sonchifolia Hance combined with Panax notoginseng saponins
Drug: Panax notoginseng saponins
Drug: Ixeris of sonchifolia Hance

Study type

Interventional

Funder types

Other

Identifiers

NCT01636154
BUCMDFH9634

Details and patient eligibility

About

The purpose of this study is to investigate the efficacy of fractions-based herbal combinations of clearing heat and promoting blood circulation treating acute ischemic stroke and the potential mechanism of it.

Full description

The interaction between fire-heat and blood stasis is a significant mechanism underlying pathogenesis and progress in acute ischemic stroke according to TCM theory.Clinical therapeutic effects are achieved with wide application of Ixeris of sonchifolia Hance components (KDZ injection) representing method of clearing heat and Panax notoginseng saponins components (Xueshuantong injection) representing method of promoting blood circulation.

Enrollment

120 patients

Sex

All

Ages

40 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with acute ischemic stroke
  • Patients with fire-heat syndrome
  • Stoke onset within 48 hours
  • NIHSS scores range from 5 points to 25 points
  • Age from forty to seventy-five,gender not limited
  • Informed and signed the consent

Exclusion criteria

  • Cardiogenic cerebral embolism,stroke caused by other reasons or the unexplained
  • Patients suitable for thrombolytic therapy(rt-PA, urokinase)
  • Patients have received thrombolytic therapy
  • Patients with serious diseases of heart,lungs,liver,kidneys
  • Patients with bleeding or bleeding tendency recently
  • Pregnant or lactating women
  • Pre-existing neurological or psychiatric diseases that could confound the study results
  • Patients be allergic to alcohol,Ixeris of sonchifolia Hance components (KDZ injection) or Panax notoginseng saponins components (Xueshuantong injection)
  • Patients have participated in other clinical trials within 3 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

120 participants in 4 patient groups

The basic treatment
No Intervention group
Description:
Comply to the Chinese guidelines of acute ischemic stroke in 2010
Clearing heat
Other group
Description:
Treat with KDZ injection on the basis of the basic treatment
Treatment:
Drug: Ixeris of sonchifolia Hance
Promoting blood circulation
Other group
Description:
Treat with Xueshuantong injection on the basis of the basic treatment
Treatment:
Drug: Panax notoginseng saponins
Clearing heat & Promoting blood circulation
Experimental group
Description:
Treat with both KDZ injection and Xueshuantong injection on the basis of the basic treatment
Treatment:
Drug: Ixeris of sonchifolia Hance combined with Panax notoginseng saponins

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems